Sunshine Biopharma Inc. Revenue 2017–2025
Sunshine Biopharma Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Sunshine Biopharma Inc. revenue for the quarter ending March 31, 2026 was 8.1 M, a 9.13% decrease year-over-year.
- Sunshine Biopharma Inc. revenue for the twelve months ending March 31, 2026 was 35.8 M, a 14.66% increase year-over-year.
- Sunshine Biopharma Inc. annual revenue for 2025 was 36.3 M, a 4.11% increase from 2024.
- Sunshine Biopharma Inc. annual revenue for 2024 was 34.9 M, a 44.75% increase from 2023.
- Sunshine Biopharma Inc. annual revenue for 2023 was 24.1 M, a 454.42% increase from 2022.
- Sunshine Biopharma Inc. annual revenue for 2022 was 4.3 M.
Sunshine Biopharma Inc. (SBFM) — Frequently Asked Questions
Sunshine Biopharma Inc. (SBFM) is a publicly traded US company. It has a market capitalization of $12M. In fiscal 2025 it reported revenue of $36M and net income of -$6M. Explore SBFM's stock price, financial statements, earnings history, margins and key ratios below.
What is Sunshine Biopharma Inc.'s market cap?
Sunshine Biopharma Inc. (SBFM) has a market capitalization of $12M.
What is the SBFM stock price?
SBFM trades at $2.39 (+11.68% on the day).
How much revenue does Sunshine Biopharma Inc. make?
Sunshine Biopharma Inc. reported revenue of $36M in fiscal 2025.
Is SBFM profitable?
In fiscal 2025, Sunshine Biopharma Inc. reported net income of -$6M.